BHVN Q1 2023 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$78M

Net Income

-$70M

EPS (Diluted)

$-1.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$78M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$619M

Total Liabilities

$146M

Stockholders' Equity

$472M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$78M	-$90M	+13.4%
Net Income	-$70M	-$97M	+27.4%